Parkman Healthcare Partners LLC bought SPRB
October 6, 2025 · Form 4 insider transaction
Parkman Healthcare Partners LLC bought 256 shares of Spruce Biosciences, Inc. at $17.91 per share, a transaction worth $4.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 9 days after the transaction.
Footnotes
The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $17.55 to $18. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.; The amount reported represents the Reporting Persons' pecuniary interest held through an investment in private funds. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.